POSTPRANDIAL METABOLISM OF APOB-CONTAINING LIPOPROTEINS APOC3 LOSS-OF-FUNCTION OR GAIN-OF-FUNCTION MUTATIONS

被引：0
|
作者：
Boren, Jan [1 ]
机构：
[1] Univ Gothenburg, Gothenburg, Sweden
来源：
ATHEROSCLEROSIS | 2024年 / 399卷
关键词：
D O I：
10.1016/j.atherosclerosis.2024.118836
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
    Crosby, Jacy
    Peloso, Gina M.
    Auer, Paul L.
    Crosslin, David R.
    Stitziel, Nathan O.
    Lange, Leslie A.
    Lu, Yingchang
    Tang, Zheng-zheng
    Zhang, He
    Hindy, George
    Masca, Nicholas
    Stirrups, Kathleen
    Kanoni, Stavroula
    Do, Ron
    Jun, Goo
    Hu, Youna
    Kang, Hyun Min
    Xue, Chenyi
    Goel, Anuj
    Farrall, Martin
    Duga, Stefano
    Merlini, Pier Angelica
    Asselta, Rosanna
    Girelli, Domenico
    Olivieri, Oliviero
    Martinelli, Nicola
    Yin, Wu
    Reilly, Dermot
    Speliotes, Elizabeth
    Fox, Caroline S.
    Hveem, Kristian
    Holmen, Oddgeir L.
    Nikpay, Majid
    Farlow, Deborah N.
    Assimes, Themistocles L.
    Franceschini, Nora
    Robinson, Jennifer
    North, Kari E.
    Martin, Lisa W.
    DePristo, Mark
    Gupta, Namrata
    Escher, Stefan A.
    Jansson, Jan-Hakan
    Van Zuydam, Natalie
    Palmer, Colin N. A.
    Wareham, Nicholas
    Koch, Werner
    Meitinger, Thomas
    Peters, Annette
    Lieb, Wolfgang
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (01): : 22 - 31
  • [2] Beneficial metabolic phenotypes caused by loss-of-function APOC3 mutations
    Gibson, W. T.
    CLINICAL GENETICS, 2015, 87 (01) : 31 - 32
  • [3] Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
    Jorgensen, Anders Berg
    Frikke-Schmidt, Ruth
    Nordestgaard, Borge G.
    Tybjaerg-Hansen, Anne
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (01): : 32 - 41
  • [4] LOSS-OF-FUNCTION MUTATIONS IN APOC3 AND REDUCED RISK OF ISCHEMIC VASCULAR DISEASE
    Jorgensen, A.
    Frikke-Schmidt, R.
    Nordestgaard, B. G.
    Tybjaerg-Hansen, A.
    ATHEROSCLEROSIS, 2014, 235 (02) : E18 - E18
  • [5] NALCN channelopathies: Distinguishing gain-of-function and loss-of-function mutations
    Bend, Eric G.
    Si, Yue
    Stevenson, David A.
    Bayrak-Toydemir, Pinar
    Newcomb, Tara M.
    Jorgensen, Erik M.
    Swoboda, Kathryn J.
    NEUROLOGY, 2016, 87 (11) : 1131 - 1139
  • [6] Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations
    Taskinen, Marja-Riitta
    Bjornson, Elias
    Matikainen, Niina
    Soderlund, Sanni
    Ramo, Joel
    Ainola, Mari-Mia
    Hakkarainen, Antti
    Sihlbom, Carina
    Thorsell, Annika
    Andersson, Linda
    Bergh, Per-Olof
    Henricsson, Marcus
    Romeo, Stefano
    Adiels, Martin
    Ripatti, Samuli
    Laakso, Markku
    Packard, Chris J.
    Boren, Jan
    JCI INSIGHT, 2022, 7 (19)
  • [7] Analysis of sperm galactosyltransferase through gain-of-function and loss-of-function mutations
    Shur, B
    Lu, QX
    Shi, XD
    Paruchuru, K
    Miller, D
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 7A - 7A
  • [8] Using SIFT and PolyPhen to Predict Loss-of-Function and Gain-of-Function Mutations
    Flanagan, Sarah E.
    Patch, Ann-Marie
    Ellard, Sian
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2010, 14 (04) : 533 - 537
  • [9] RARE LOSS-OF-FUNCTION MUTATIONS IN THE APOC3 GENE, PLASMA TRIGLYCERIDES, AND RISK FOR CORONARY HEART DISEASE
    Kathiresan, S.
    ATHEROSCLEROSIS, 2014, 235 (02) : E30 - E31
  • [10] LOSS-OF-FUNCTION MUTATIONS IN APOC3, REMNANT CHOLESTEROL, LDL CHOLESTEROL, AND RISK OF ISCHEMIC VASCULAR DISEASE
    Jorgensen, A. B.
    Frikke-Schmidt, R.
    Nordestgaard, B.
    Tybjaerg-Hansen, A.
    ATHEROSCLEROSIS, 2016, 252 : E251 - E252
12345